Skin Diseases Completed Phase 2 Trials for Baricitinib (DB11817)

Also known as: Skin Disease / Iatrogenic dermatosis / Disease of skin (disorder) / Skin disorder / Dermatosis / Skin disorder NOS

IndicationStatusPhase
DBCOND0028161 (Skin Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01490632A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisTreatment